npj Precision Oncology

Article	Citations
KMT2C inactivation leads to PTEN downregulation and tolerance to DNA damage during cell cycle progression	450
MYSM1 promotes lung adenocarcinoma progression via TRAF2/3-mediated activation of MAPK and non-canonical NF-κB pathways	232
Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies	171
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson	159
High-throughput screening identifies NT-1 that synergizes with MRTX1133 against acquired resistant KRASG12D colorectal cancer	152
Improved prediction of MAPKi response duration in melanoma patients using genomic data and machine learning	151
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates	151
Multi-modal characterization of metabolic and immune gene clusters in adrenocortical carcinoma treatment	147
Barriers and opportunities in pancreatic cancer immunotherapy	133
Author Correction: An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study	115
Genome-wide analyses reveals an association between invasive urothelial carcinoma in the Shetland sheepdog and NIPAL1	106
AI-enabled single-cell dissection of the palmitoylation landscape identifies a multicellular prognostic program in gastric cancer	102
Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood	96
Sub-regional radiomics combining multichannel 2-dimensional or 3-dimensional deep learning for predicting neoadjuvant chemo-immunotherapy response in esophageal squamous cell carcinoma: a multicenter	94
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada	83
Mucin-1: a promising pan-cancer therapeutic target	78
Constitutional mismatch repair deficiency mimicking Lynch syndrome is associated with hypomorphic mismatch repair gene variants	77
Exosome- transported FER inhibitor suppresses progression of diffuse large B-cell lymphoma via regulating AJUBA/Hippo axis	76
Circulating tumor DNA in ALK-positive anaplastic large cell lymphoma: a proof-of-concept study	76
Artificial intelligence-driven prediction of lymph node metastasis in T1 esophageal squamous cell carcinoma using whole slide images	73
Development and testing of a polygenic risk score for breast cancer aggressiveness	72
The dynamic immune behavior of primary and metastatic ovarian carcinoma	68
Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs	68
Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trials	67
An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study	67

Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI)	65
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3	64
BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study	64
Patient-level proteomic network prediction by explainable artificial intelligence	63
Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers	59
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes	59
Single nuclei and spatial profiling of sacrococcygeal teratomas reveals cellular composition and X inactivation heterogeneity	58
Deciphering brain metastasis in epithelial ovarian cancer: multimodal analysis and potential biomarkers	58
Spatial transcriptomics reveals molecular heterogeneity and subtype-specific therapeutic targets in small cell lung cancer	58
Interferon signaling and ferroptosis in tumor immunology and therapy	57
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP	56
Collagen disorder architecture features are associated with clinical, molecular, genetic factors and survival outcomes in colon cancer	55
Single-cell landscape of bronchoalveolar immune cells in patients with immune checkpoint inhibitor-related pneumonitis	54
m6A reader IGF2BP2-stabilized lncRNA LHX1-DT inhibits renal cell carcinoma (RCC) cell proliferation and invasion by sponging miR-590-5p	53
Targeting Nrf2/PHKG2 axis to enhance radiosensitivity in NSCLC	52
Enhanced efficacy of ipilimumab plus nivolumab in angiogenic subtypes of metastatic clear-cell renal cell carcinoma	52
Discovery of prognostic lncRNAs in colorectal cancer using spatial transcriptomics	50
Stage-dependent spatial distribution and prognostic value of CD8+ tissue-resident memory T cells in NSCLC	49
Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patients	48
Erigoster B targeting DECR1 induces ferroptosis of breast cancer cells via promoting phosphatidylcholine/arachidonic acid metabolism	48
Self-supervised attention-based deep learning for pan-cancer mutation prediction from histopathology	47
AI-driven body composition atlas reveals its association with NSCLC immunotherapy outcome and molecular background: a multicenter study	47
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma	46
Prolonged response to dual immune checkpoint blockade in patients with advanced solid tumors: a case series	45
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab	45
TRIM65 regulates glucose metabolic reprogramming to promote glioma cell proliferation via ubiquitination and degradation of AMPK	44
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays	43
Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer – results from the Tumor Profiler Melanoma project	43
A universal immunohistochemistry analyzer for generalizing AI-driven assessment of immunohistochemistry across immunostains and cancer types	41
ECM-based molecular subtypes define prognostic, EMT status, and therapeutic diversity in IDH-mutant gliomas	41
User-centered design approach to visualize PROMs for molecular tumor boards	41
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading	40
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells	40
Prospective implementation of an aqueous humor liquid biopsy platform informs clinical diagnosis and management of retinoblastoma and other intraocular lesions	40
Venetoclax resistance in preclinical KMT2A-rearranged acute lymphoblastic leukemia models is characterized by high inter- and intra-model heterogeneity	40
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy	39
Establishing predictive machine learning models for drug responses in patient derived cell culture	39
Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer	38
Machine learning model for predicting tertiary lymphoid structures and treatment response in triple-negative breast cancer	37
A core driver gene set identified based on geMER reveals its potential driver mechanism in pan-cancer	37
Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancer	37
Compound heterozygous MSH3 germline variants and associated tumor somatic DNA mismatch repair dysfunction	37
Personalized signaling pathway analysis of gastrointestinal tumors for patient stratification and drug target evaluation using clinically derived core biopsies	37
Multiregional transcriptomic profiling provides improved prognostic insight in localized non-small cell lung cancer	37
First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound	37
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials	36
The hegemonic EWSR1::ETS oncoprotein overrules core regulatory circuitry principles in Ewing sarcoma	36
Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance	35
Author Correction: Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies	35
The SMARCA4R1157W mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer	35

Deciphering associations between three RNA splicing-related genetic variants and lung cancer risk	35
Organ-metastatic landscape delineates overall and site-specific immune-related adverse events of PD-L1 blockade in advanced NSCLC	34
Prediction of molecular subtypes from histology: AI-driven analysis of prostate cancer morphological patterns and therapeutic implications	34
HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells	34
AI-driven eyelid tumor classification in ocular oncology using proteomic data	34
Integrating liquid biopsy and mutational signatures to advance precision oncology	33
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers	33
Clonal determinants of organotropism and survival in metastatic uveal melanoma	33
APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer	33
Validation of histopathology-based deep learning algorithms for detection of actionable non-small cell lung cancer biomarkers	33
Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET–mutant thyroid cancer	32
In-depth inference of transcriptional regulatory networks reveals NPM1 as a therapeutic ribosomal regulator in MYC-amplified medulloblastoma	32
Translating spatial transcriptomic signatures in adenosquamous carcinoma into bulk prognostic biomarkers in lung adenocarcinoma: a bottom-up approach	32
A large-scale, multi-centre validation study of an AI-empowered blood-based test for multi-cancer early detection	31
ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma	31
Deciphering the liver’s role in pancreatic cancer metastasis: pathways and therapeutic approaches	31
Machine learning algorithms for predicting glioma patient prognosis based on CD163+FPR3+ macrophage signature	31
Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies	31
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition	31
Enhancing adoptive cell therapy: future strategies for immune cell radioprotection in neuro-oncology	31
Progress in personalized immunotherapy for patients with brain metastasis	31
Augmented reality microscopy to bridge trust between AI and pathologists	30
Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma	30
A multimodal fusion system predicting survival benefits of immune checkpoint inhibitors in unresectable hepatocellular carcinoma	30
EPAS1 increases SDHA to inhibit proliferation of multiple myeloma cells by restoring TCA Cycle	30
Multiclass machine learning models for molecular subtype identification of pediatric low-grade glioma using bi-institutional MRIs for precision medicine	29
Potential of pre-diagnostic metabolomics for colorectal cancer risk assessment or early detection	29
ALK fusions in the pan-cancer setting: another tumor-agnostic target?	29
A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer	29
Fractal analysis of longitudinal MRI for predicting response to neoadjuvant chemotherapy in breast cancer	28
Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery	28
Targeting tumoral heterogeneity in lung cancer: a novel, CT-texture-guided targeted biopsy approach with exome sequencing	28
Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer	28
Treatment adherence and clinical outcomes of osimertinib in minority patients with advanced EGFR mutated NSCLC	28
Unlocking the potential of TIGIT in enhancing therapeutic strategies for acute myeloid leukemia through combined azacitidine therapy	28
Survival prediction and risk stratification in R0-resected ovarian cancer: a multi-modal deep learning approach	28
Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment	27
Personalized chronotherapy in glioblastoma: integrating circadian profiling and PK–PD modelling to optimize temozolomide timing	27
Artificial intelligence-based assessment of PD-L1 expression in diffuse large B cell lymphoma	27
Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric study	27
Optical genome mapping as a high-resolution tool for uncovering cytogenetic complex and cryptic alterations in a cohort of patients with MDS and AML	27
A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironment	27
Multi-output prediction of dose–response curves enables drug repositioning and biomarker discovery	27
Role of large language models in the multidisciplinary decision-making process for patients with renal cell carcinoma: a pilot experience	27
MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis	26
Integration of radiomics, deep learning, transcriptomics, and metabolomics reveals prognostic risk stratification and underlying biological mechanisms in colorectal cancer	26
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population	26
SLC25A1 upregulation promotes HNSCC cisplatin resistance via H3K27ac-mediated cellular senescence	26
Artificial intelligence-based epigenomic, transcriptomic and histologic signatures of tobacco use in oral squamous cell carcinoma	26
Colorectal cancer risk stratification on histological slides based on survival curves predicted by deep learning	25
A multi-cancer early detection blood test using machine learning detects early-stage cancers lacking USPSTF-recommended screening	25
ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial	25
CDK4/6i reverse PARPi resistance by targeting the E2F1- MCM2/5 pathway	25
Targeting high-risk MYC-overexpressed osteosarcoma with an Aurora kinase inhibitor:--results from a pilot umbrella trial	25
Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment	25
CNTNAP4 signaling regulates osteosarcoma disease progression	25
Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approach	24
Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration	24
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia	24
ARHGAP4/MYH9/β-catenin/c-Jun positive feedback loop promotes colorectal cancer stemness	24
ASF1B promotes gastric cancer liver metastasis through inhibiting ZDHHC9/PCBP1/ SLC7A11 signaling axis mediated ferroptosis	24
Personalized prediction of anticancer potential of non-oncology drugs through learning from genome derived molecular pathways	24
Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention	24
RICH1 enhances pro-inflammatory TAM infiltration in breast cancer via promoting TRIM21-mediated ubiquitination of RhoA and inhibiting STAT3 phosphorylation	24
The regulatory roles and therapeutic strategies of the solute carrier transporters in cancer metabolism	24
Deep learning-based quantification of eosinophils and lymphocytes shows complementary prognostic effects in colorectal cancer patients	24
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer	24
Development and interpretation of a multimodal predictive model for prognosis of gastrointestinal stromal tumor	24
HER2 expression in cervical squamous cell carcinoma: high prevalence of HER2-low/ultralow and spatiotemporal heterogeneity across tumor evolution	24
Germline pathogenic variants in DNA repair pathways: a key feature in a significant subset of translocation-associated sarcomas	23
APOE-high myeloid cells are uniquely associated with metastatic intrathoracic lymph nodes obtained by EBUS-TBNA in primary lung cancer	23
LINE1 insertion into the NACC2 locus disrupts the HDM2 axis and activates lung oncogenic signaling	23
Co-clinical trial targeting ER, FGFR and CDK4/6 in resistant hormone-positive breast cancer with FGFR alterations	23
Predicting colorectal cancer survival by combined c-reactive protein and tumor immune score	23
Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AML	23
PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancer	22
Ultrasensitive ctDNA monitoring for organ preservation in patients with locally advanced rectal cancer	22
Therapeutic vulnerabilities exposed by the 9p21 loss identified through multiparametric drug screening inform rational combination strategies	22
Genetic and oncogenic features of RASGRF fusions	21
Author Correction: HDAC6 facilitates LUAD progression by inducing EMT and enhancing macrophage polarization towards the M2 phenotype	21

Mapping immunosuppressive terrain in high-grade serous ovarian cancer: tumor-intrinsic, stromal, and spatial drivers of therapy response	21
ACACA modulates R-loop homeostasis to enhance lipid metabolism and microenvironmental interactions in ccRCC	21
An integrated single-cell lung cancer atlas reveals distinct fibroblast phenotypes between adenocarcinoma and squamous cell carcinomas	21
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers	21
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer	21
Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection	21
Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule	20
Author Correction: A targetable OSGIN1–AMPK–SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosis	20
Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusion	20
Clock pathway inhibitor overcomes tumor immune-exclusion via regulation of fibrocyte differentiation	20
Ligand-receptor interactions combined with histopathology for improved prognostic modeling in HPV-negative head and neck squamous cell carcinoma	20
Complete response to fifth-line anti-PD-1 rechallenge in fumarate hydratase-mutated papillary renal cell carcinoma	20
Potential utility of risk stratification for multicancer screening with liquid biopsy tests	20
Predicting survival in prospective clinical trials using weakly-supervised QSP	19
Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma	19
Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy	19
Whole-genome analysis of an aggressive metastatic pancreatic solid pseudopapillary neoplasm	19
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer	19
AI-driven multi-omics integration of cancer-associated fibroblasts for prognostic modeling and therapeutic target discovery in head and neck squamous cell carcinoma	19
Multimodal fusion of pathology and radiology foundation models for WHO 2021 glioma subtyping	19
Design of self-assembled micelles based on natural dual-targeting strategies and evaluation of their anti-liver cancer effects as drug delivery systems	19
Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling	19
Author Correction: Predicting the tumor microenvironment composition and immunotherapy response in non-small cell lung cancer from digital histopathology images	19
Opportunities and challenges for patient-derived models of brain tumors in functional precision medicine	19
Novel paediatric case of a spinal high-grade astrocytoma with piloid features in a patient with Noonan Syndrome	19
Machine learning-driven multi-targeted drug discovery in colon cancer using biomarker signatures	19
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan	19
Deepath-SCC: a deep learning model for accurate tissue origin identification in squamous cell carcinoma	18
Validation of QuANTUM-derived tumor cell fraction for molecular testing in high-grade serous tubo-ovarian carcinoma	18
Tertiary lymphoid structures potentially promote immune checkpoint inhibitor response in SMARCB1-deficient medullary renal cell carcinoma	18
Impact of TP53 mutations in Triple Negative Breast Cancer	18
GZMK expression within activated intratumoral T-cell subsets reflects differentiation efficiency and predicts response to cancer immunotherapy	18
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system	18
Targeting histone deacetylation, cell cycle regulators and heat shock proteins as novel therapeutic strategies for penile cancers	18
Multi-omics analyses reveal interactions between GREM1+ fibroblasts and SPP1+ macrophages in gastric cancer	18
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients	18
Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma	18
Bladder cancer diagnostic and prognostic models from DNA methylation by multi algorithm machine learning	18
A review of machine learning methods for cancer characterization from microbiome data	18
HDAC6 facilitates LUAD progression by inducing EMT and enhancing macrophage polarization towards the M2 phenotype	18
COL3A1high cancer-associated fibroblasts orchestrate metabolic and immune microenvironments to confer chemoresistance in breast cancer	18
Progress and challenges of artificial intelligence in lung cancer clinical translation	17
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology	17
DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment	17
Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy	17
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer	17
A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition	17
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors	17
Multi-omics analysis deciphers intercellular communication regulating oxidative stress to promote oral squamous cell carcinoma progression	16
Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predisposition	16
Single-cell transcriptome sequencing reveals spatial distribution of IL34+ cancer-associated fibroblasts in hepatocellular carcinoma tumor microenvironment	16
Element-specific estimation of background mutation rates in whole cancer genomes through transfer learning	16
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer	16
An appraisal of genetic testing for prostate cancer susceptibility	16
Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome	16
Integrative immune subtyping of HNSCC reveals clinically relevant phenotypes and treatment-associated transitions	16
Multi-omics analysis reveals NNMT as a master metabolic regulator of metastasis in esophageal squamous cell carcinoma	16
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer	16
Prediction and analysis of tumor infiltrating lymphocytes across 28 cancers by TILScout using deep learning	16
A comprehensive analysis of minimally differentially methylated regions common to pediatric and adult solid tumors	16
Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma	16
Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning	16
Integrative whole slide image and spatial transcriptomics analysis with QuST and QuPath	16
Multimodal spatial proteomic profiling in acute myeloid leukemia	16
Defining the extracellular matrix for targeted immunotherapy in adult and pediatric brain cancer	16
Plasma cell-free DNA methylation-based prognosis in metastatic castrate-resistant prostate cancer	16
Large scale quantification of natural killer cell-induced apoptosis in patient-derived organoids reveals intratumoral response heterogeneity	16
Valproic acid reverses macrophage-mediated temozolomide resistance in macrophage-rich gliomas	16
RadGLO: an interactive platform for radiomic feature analysis and prognostic modeling in glioma	15
Deep learning-based detection and semi-quantitative model for spread through air spaces (STAS) in lung adenocarcinoma	15
Spatial tumor immune microenvironment phenotypes in ovarian cancer	15
Cell graph neural networks enable the precise prediction of patient survival in gastric cancer	15
All models are wrong and yours are useless: making clinical prediction models impactful for patients	15
Modeling glioblastoma relapse in vitro: a critical journey from 2D models to organ-on-chip alternatives	15
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer	15
CAR-macrophages in solid tumors: promise, progress, and prospects	15
Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosis	15
Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma	15
The next layer: augmenting foundation models with structure-preserving and attention-guided learning for local patches to global context awareness in computational pathology	15
Secrets of DNA-PKcs beyond DNA repair	15
GLMP promotes EGFR-TKI resistance by activating autophagy and RhoA pathway in non-small cell lung cancer	15
Accurate prediction of disease-free and overall survival in non-small cell lung cancer using patient-level multimodal weakly supervised learning	15
Survival-inferred fragility of statistical significance in phase III oncology trials	15
Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapy	14
Enhancing decision-making in glioblastoma surgery through an explainable human-AI collaboration: an international multicenter model development and external validation study	14
Bayesian risk prediction model for colorectal cancer mortality through integration of clinicopathologic and genomic data	14
FUT3 mediated GRP78 fucosylation promotes colorectal cancer survival and proliferation under glucose restriction via PERK/ATF4/STC2 axis	14
Revealing neuroendocrine transformation in gynecological cancers through genomic analysis	14
ADNEX-AI: automated extraction of ultrasound predictors for interpretable ovarian cancer risk stratification	14
A machine learning-based framework for prognostic prediction and tumor microenvironment characterization of locally advanced cervical cancer with concurrent chemoradiotherapy	14
Unsupervised generative AI for enhancing brain tumor segmentation in multi-center, incomplete real-world data scenarios	14
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology	14
A machine learning-defined cellular senescence signature systematically enhances prognostication and guides immunotherapy strategies for the treatment of gliomas	14
Neoadjuvant therapy-induced immune dynamics and myeloid-associated resistance in advanced head and neck cancer	14
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression	14